Impact of preoperative breast MRI on 10-year survival of patients included in the Swedish randomized multicentre POMB trial
Open Access
- 6 October 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 5 (5)
Abstract
The value of preoperative breast MRI as an adjunct technique regarding its effect on re-excision rates has been a subject of discussion. No survival data regarding preoperative breast MRI are available from randomized studies. Ten-year follow-up of the POMB randomized multicentre study was analysed, evaluating MRI and its effect on disease-free survival (DFS) and overall survival (OS). Patients with newly diagnosed breast cancer were randomized to either preoperative MRI or conventional imaging. Kaplan–Meier plots were used to analyse DFS and OS, and Cox regression to estimate hazard ratios (HRs). A total of 440 patients, aged 56 years or less, with newly diagnosed breast cancer were randomized to either preoperative MRI (220) or conventional imaging (220; control). Median follow-up for each group was 10 years. DFS rates were 85.5 and 80.0 per cent for the MRI and control groups respectively (P = 0.099). The risk of relapse or death was 46 per cent higher in the control group (HR 1.46, 95 per cent c.i. 0.93 to 2.29). OS rates after 10 years were 90.9 and 88.6 per cent in the MRI and control groups respectively (P = 0.427). The risk of death was 27 per cent higher in the control group (HR 1.27, 0.71 to 2.29). Locoregional, distant, and contralateral recurrence outcomes combined were increased in the control group (P = 0.048). A subgroup analysis of patients with breast cancer stages I–III showed that preoperative MRI improved DFS compared with conventional imaging, but this did not reach statistical significance (P = 0.057). After 10 years of follow-up, preoperative breast MRI as an adjunct to conventional imaging resulted in slightly, but non-significantly, improved DFS and OS. Registration number: NCT01859936 (http://www.clinicaltrials.gov).Keywords
Funding Information
- Capio St Goran’s Hospital Research Foundation
- Centre for Clinical Research, Vastmanland Hospital, Vasteras
- Percy Falk Foundation
- Vastmanland Research Foundation against Cancer
This publication has 33 references indexed in Scilit:
- Accuracy and Surgical Impact of Magnetic Resonance Imaging in Breast Cancer Staging: Systematic Review and Meta-Analysis in Detection of Multifocal and Multicentric CancerJournal of Clinical Oncology, 2008
- Predictors of Breast Asymmetry after Breast-Conserving Operation for Breast CancerJournal of the American College of Surgeons, 2008
- Relationship of Breast Magnetic Resonance Imaging to Outcome After Breast-Conservation Treatment With Radiation for Women With Early-Stage Invasive Breast Carcinoma or Ductal Carcinoma in SituJournal of Clinical Oncology, 2008
- A Clinical Oncology Perspective on the Use of Breast MRMagnetic Resonance Imaging Clinics of North America, 2006
- Eighteen‐year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapyCancer, 2003
- Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imagingCancer, 2003
- Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast CancerNew England Journal of Medicine, 2002
- Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast CancerNew England Journal of Medicine, 2002
- Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM)European Journal of Cancer, 1999
- Stopping Metastases at Their SourceNew England Journal of Medicine, 1997